Under the agreement, Lorus has purchased all of the Debentures from TEMIC for a cash payment of $3.3 million, the assignment of the rights under the license agreement with ZOR Pharmaceuticals, LLC (ZOR) (described below), sale of intellectual property associated with Virulizin and sale of Lorus' shares in its wholly owned subsidiary Pharma Immune Inc. which holds an equity interest in ZOR (the "Consideration"). Under the agreement, Lorus will be entitled to 50% of any royalties received under the ZOR license agreement and 50% of the deal value of any transaction completed in territories not covered by the ZOR license agreement. Lorus also retains a perpetual, royalty free license for the animal use of Virulizin. TEMIC will be fully responsible for all clinical and regulatory costs associated with commercialization of Virulizin in territories not covered by the ZOR license agreement. Lorus will assist TEMIC with certain agreed upon services."
I think this is going to keep Lorus alive and kicking. Maybe actually make money some day.
Norman
Recent APTO News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:20:21 PM
- Aptose Announces Results from Special Meeting of Shareholders • GlobeNewswire Inc. • 09/05/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:35:07 PM
- Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib • GlobeNewswire Inc. • 08/30/2024 08:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:35:12 PM
- Aptose Announces Adjournment of its Special Meeting of Shareholders • GlobeNewswire Inc. • 08/15/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:22:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 09:15:13 PM
- Aptose Reports Results for the Second Quarter 2024 • GlobeNewswire Inc. • 08/08/2024 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:00:14 PM
- Aptose Announces Receipt of Deficiency Notice from Nasdaq • GlobeNewswire Inc. • 07/19/2024 09:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/17/2024 03:43:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:40:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:35:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 02:32:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 10:05:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 12:05:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/15/2024 03:47:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:06:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:15:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 03:35:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:45:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:00:16 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM